Eli Lilly has the advantage now, says the Barclays analyst.
发布者:BY CHRISTIAN BUNDGAARD,转转请注明出处:https://robotalks.cn/analyst-novo-nordisk-has-a-credibility-problem/
Eli Lilly has the advantage now, says the Barclays analyst.
发布者:BY CHRISTIAN BUNDGAARD,转转请注明出处:https://robotalks.cn/analyst-novo-nordisk-has-a-credibility-problem/